U.S. Markets close in 2 hrs 5 mins

GlyEco Reports Third Quarter 2016 Results

Quarter and Year to Date Positive Gross Margin
Adjusted Revenues Increased 9% for the Quarter
Net Loss Decreased 5% for the Quarter

ROCK HILL, SC / ACCESSWIRE / November 14, 2016 / A leader in sustainable glycol technologies, GlyEco, Inc. ("GlyEco" or the "Company") (GLYE), announced today the following financial results for its quarter ended September 30, 2016:

"The Company's financial performance for the quarter ended September 30, 2016, improved compared to the sequential quarter ended June 30, 2016, as well as the comparable quarter in 2015. The departure from our New Jersey location, improved adjusted revenues and increased distillation production all contributed to our improved financial performance," said Grant Sahag, GlyEco's President and Chief Executive Officer. "We saw the benefit of the infrastructure improvements we made in the first half of 2016, as well as early positive indications from our new sales efforts. The completion of our Quality, Research, and Development Laboratory and the hiring of a new Vice President of Sales and Marketing were also important accomplishments during the quarter."

Third Quarter of 2016 Highlights

  • Positive gross margin of $106 thousand for the three months ended September 30, 2016, compared to a negative gross margin of $98 thousand for the three months ended September 30, 2016
  • Hired a new Vice President of Sales and Marketing
  • Completed our quality, development and research laboratory
  • Reached a new milestone of 74,000 gallons of monthly distillation production in September 2016. Average monthly distillation production was 63,000 gallons for the three months ended September 30, 2016.
  • Increased Revenues (net of revenues related to our Elizabeth, NJ facility) by $102 thousand or 9%, from $1.19 million for the three months ended September 30, 2015, to $1.29 million for the three months ended September 30, 2016
  • Operating loss of $693 thousand for the three months ended September 30, 2016, compared to $694 thousand for the three months ended September 30, 2015
  • Adjusted EBITDA of negative $336 thousand for the three months ended September 30, 2016, compared to negative $323 thousand for the three months ended September 30, 2015

Third Quarter of 2016 Financial Review

The Company's sales were $1.39 million for the quarter ended September 30, 2016, compared to $2.14 million for the quarter ended September 30, 2015, a decrease of $753 thousand or 35%. The decrease in sales was due to the impact of the closure of our former New Jersey processing center in 2015, partially offset by the addition of new customers.

The Company realized a gross profit of $106 thousand for the quarter ended September 30, 2016, compared to a gross loss of $98 thousand for the same period ended September 30, 2015, as cost of goods sold decreased primarily as a result of the closure of the New Jersey processing facility in December 2015.

The Company reported an operating loss of $693 thousand for the quarter ended September 30, 2016, compared to a $694 thousand operating loss for the quarter ended September 30, 2015, as the improvement in gross margin was offset by increased operating expenses primarily related to salaries and wages. Salaries and wages increased year over year due to the hiring of a Chief Financial Officer, shifting technical consulting activities to full-time in-house resources, and transitioning the accounting of our technical team to corporate overhead.

The Company reported a net loss of $699 thousand for the quarter ended September 30, 2016, compared to $734 thousand for the quarter ended September 30, 2015.

The Company reported adjusted EBITDA of negative $336 thousand for the three months ended September 30, 2016, compared to negative $323 thousand for the three months ended September 30, 2015.

First Nine Months of 2016 Financial Review

The Company's sales were $4.15 million for the nine months ended September 30, 2016, compared to $5.53 million for the nine months ended September 30, 2015, a decrease of $1.38 million or 25%. The decrease in sales was due to the impact of the closure of our former Elizabeth, New Jersey processing center in 2015, partially offset by the addition of new customers.

The Company realized a gross profit of $177 thousand for the nine months ended September 30, 2016, compared to a gross loss of $445 thousand for the same period ended June 30, 2015, as cost of goods sold decreased primarily as a result of the closure of our Elizabeth, New Jersey processing facility in December 2015.

The Company reported an operating loss of $2.54 million for the nine months ended September 30, 2016, compared to a $2.66 million operating loss for the nine months ended September 30, 2015, as the improvement in gross margin was partially offset by increased operating expenses related to salaries and wages and general and administrative expenses. Salaries and wages increased year over year due to the hiring of a Chief Financial Officer, shifting technical consulting activities to full-time in-house resources, and transitioning the accounting of our technical to corporate overhead. General and administrative expenses increased year over year due to wind down costs related to our Elizabeth, New Jersey facility.

The Company reported a net loss of $2.55 million for the nine months ended September 30, 2016, compared to $2.79 million for the nine months ended September 30, 2015.

The Company reported adjusted EBITDA of negative $1.43 million for the nine months ended September 30, 2016, compared to negative $1.26 million for the nine months ended September 30, 2015.

Business Update

"After realigning our business model and investing in our six distribution facilities in the first half of 2016, we realized returns on those investments in the third quarter. In the first quarter, we refocused our business model on providing glycol solutions through a network of fully-integrated collection and direct-delivery channels, rather than a business so entrenched in the glycol commodity manufacturing business. In the second quarter, we invested in the operations, production capacity, and sales structure of that fully integrated network. In the third quarter, we realized returns on our investment in production and facilities, increasing our total production volume by over 33% from the second quarter of this year. Building from a base of our sales and customer service team, we added a Vice President of Sales and Marketing to construct a comprehensive sales organization and system. We expect to see the benefit of the sales team both in the size of customers we bring in and the price we sell to those customers for. We provide solutions to our customers, not just products, and we continue to hear from them that the convenience of our solutions are what strikes true to their needs. The 12% improvement in gross margin for both the three-month and nine-month periods ending September 30th, 2016 versus the same periods in 2015 indicate a stronger financial model and position for this company. To further increase that margin, we need to continue to see improvements in production and sales, along with cheaper raw materials and more efficient distribution of our products. The managing partners of our facilities are equipped to optimize existing business and grow through new business," said Grant Sahag, GlyEco's President and Chief Executive Officer..

"In concert with the realignment of our business model, we have continued to eliminate distractions and focus on innovation. We came to a settlement with the landlord at our previous New Jersey facility and expect to wind down the remaining items in the coming months. We also finished the build out of our Quality, Research, and Development Laboratory, which will allow us to lead innovation in the glycol space," Sahag added.

"Our focus is clear. We must continue to decrease our raw material costs, produce at record volumes, attract larger customers while growing smart, attract and retain high quality members of our team, invest in our people through training, and innovate. We still have lots of work to do, but we have become smarter and better in our mission to be the best and brightest glycol recycling and distribution business in the country."

About GlyEco, Inc.

GlyEco is a collector, manufacturer, and distributor of glycol products sold to automotive and industrial customers throughout the United States. Our six facilities deliver superior quality glycol products through a fully-integrated solutions platform. We are dedicated to providing solutions, not just products: consistent, timely, and customized service; environmentally safe handling of waste; product and technology education; and technical performance support.

For further information, please visit: http://www.glyeco.com

To partner or to start a project with us, please visit: Start a Project with GlyEco!

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by the words "believe," "anticipate," "expect," "intend," "estimate," and similar expressions. All statements in this document regarding the future outlook related to GlyEco, Inc. are forward-looking statements. Such statements are based on the current expectations, beliefs, estimates and projections of management and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements including the risk that the future data will not be as favorable as the initial results. Additional uncertainties and risks are described in our most recent Annual Report on Form 10-K. For a more detailed discussion of factors that affect GlyEco's operations, please refer our filings with the Securities and Exchange Commission ("SEC"). Copies of these filings are available through the SEC website at http://www.sec.gov. All forward-looking statements are based upon information available to us on the date hereof, and GlyEco undertakes no obligation to update this forward-looking information.

Contact:

GlyEco, Inc.
Ian Rhodes
Chief Financial Officer
irhodes@glyeco.com
866-960-1539

GLYECO, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Balance Sheets
September 30, 2016 and December 31, 2015

GLYECO, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Operations
For the three and nine months ended September 30, 2016 and 2015

GLYECO, INC. AND SUBSIDIARIES
Unaudited Adjusted Earnings before Interest, Taxes, Depreciation and Amortization (non-GAAP)
For the three and nine months ended September 30, 2016 and 2015

Presented above is the non-GAAP financial measure representing earnings before interest, taxes, depreciation, amortization and stock compensation (which we refer to as "Adjusted EBITDA") and the reconciliations of Adjusted EBITDA to net loss. Adjusted EBITDA should be viewed as supplemental to, and not as an alternative for, net income (loss) and cash flows from operations calculated in accordance with GAAP.

Adjusted EBITDA is used by our management as an additional measure of our Company's performance for purposes of business decision-making, including developing budgets, managing expenditures, and evaluating potential acquisitions or divestitures. Period-to-period comparisons of Adjusted EBITDA help our management identify additional trends in our Company's financial results that may not be shown solely by period-to-period comparisons of net income (loss) and cash flows from operations. In addition, we may use Adjusted EBITDA in the incentive compensation programs applicable to many of our employees in order to evaluate our Company's performance. Further, we believe that the presentation of Adjusted EBITDA is useful to investors in their analysis of our results and helps investors make comparisons between our company and other companies that may have different capital structures, different effective income tax rates and tax attributes, different capitalized asset values and/or different forms of employee compensation. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, particularly those items that are recurring in nature. In order to compensate for those limitations, management also reviews the specific items that are excluded from Adjusted EBITDA, but included in net income (loss), as well as trends in those items.

SOURCE: GlyEco, Inc.

  • See what the IHS Markit Score report has to say about Tegna Inc.
    Business
    Markit

    See what the IHS Markit Score report has to say about Tegna Inc.

    NYSE:TGNA Score: Negative (8) 5 days at current score. Downgraded from Neutral on December 7th 2018 Summary This company ranked negatively compared to the Consumer Services sector despite 2 positive IHS Markit Categories Perception of the company's creditworthiness is negative Bearish sentiment is low Economic output in this company's sector is expanding Short interest | Positive Short interest is low for TGNA with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

  • The Timken Company (TKR)Hedge Funds Are Snapping Up
    Business
    Insider Monkey

    The Timken Company (TKR)Hedge Funds Are Snapping Up

    In this article we will check out hedge fund activity in another small-cap stock: The Timken Company (NYSE:TKR). The Timken Company (NYSE:TKR) shareholders have witnessed an increase in hedge fund interest lately. Our calculations also showed that tkr isn't among the 30 most popular stocks among hedge funds.

  • Why Schlumberger Stock Dropped 12.1% in November
    Business
    Motley Fool

    Why Schlumberger Stock Dropped 12.1% in November

    What happened Shares of the world's largest oil-field services company, Schlumberger (NYSE: SLB), fell 12.1% in November, according to data provided by S&P Global Market Intelligence. That was relatively consistent with the overall oil-field services industry, as measured by the SPDR Oil & Gas Equipment and Services ETF, which fell 12.7% for the month. Schlumberger's performance was also middle-of-the-pack when compared to its biggest rivals.

  • 3 Reasons XPO Logistics Stock Is Tumbling Further After Dropping 15.1% in November
    Business
    Motley Fool

    3 Reasons XPO Logistics Stock Is Tumbling Further After Dropping 15.1% in November

    What happened XPO Logistics (NYSE: XPO) shares can't seem to find the floor. After a painful double-digit drop in October, investors hoping for some relief were in for a rude shock as the stock tumbled 15.1% in November, according to data provided by S&P Global Market Intelligence. As if that wasn't enough, XPO shares have already lost another 12% so far in December, now stretching their three-month loss to (hold your breath) a staggering 40%.

  • Opening Bell, December 12, 2018
    Business
    CNBC Videos

    Opening Bell, December 12, 2018

    Ringing today's opening bells are Tencent Music Entertainment, a China-based music streaming company, with CEO Cussion Kar Shun Pang at the NYSE and South State Corporation with CEO Robert R. Hill Jr. at the Nasdaq.

  • Is Matthews Asia Dividend Fund Investor (MAPIX) a Strong Mutual Fund Pick Right Now?
    Finance
    Zacks

    Is Matthews Asia Dividend Fund Investor (MAPIX) a Strong Mutual Fund Pick Right Now?

    MAPIX possesses a Zacks Mutual Fund Rank of 2 (Buy), which is based on nine forecasting factors like size, cost, and past performance. MAPIX is one of many Pacific Rim - Equity funds to choose from. Pacific Rim - Equity mutual funds typically invest in companies throughout the dominant export-focused markets of Hong Kong, Singapore, Taiwan, and Korea.

  • Do Hedge Funds Love Cimarex Energy Co (XEC)?
    Business
    Insider Monkey

    Do Hedge Funds Love Cimarex Energy Co (XEC)?

    Our research has shown that hedge funds' small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the market by 18 percentage points since May 2014 through December 3, 2018 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017.

  • Better Buy: Sirius XM vs. Spotify
    Business
    Motley Fool

    Better Buy: Sirius XM vs. Spotify

    The biggest fear through the first couple of years after Sirius XM hit rock bottom was that streaming apps would spell the end of satellite radio. Connected cars that allow smartphone apps to stream seamlessly through Bluetooth connectivity would be the end of premium-priced satellite-beamed platforms. Sirius XM is still growing, but now there's a legitimate threat in the premium app realm with Spotify Technology (NYSE: SPOT) pumping up the volume.

  • Deadline approaching in Cigna/Saint Francis contract dispute
    Business
    American City Business Journals

    Deadline approaching in Cigna/Saint Francis contract dispute

    The proverb that there are two sides to every story seems apt for the protracted contract negotiations between one of Memphis’ largest hospital systems and a national health insurer. National health insurance company Cigna and one of the largest for-profit health systems, Tenet Healthcare, have failed to reach a contract agreement following 11 months of negotiations. Tenet is the parent company of Memphis-based Saint Francis Healthcare.

  • Why Uxin Stock Jumped Wednesday
    Business
    Motley Fool

    Why Uxin Stock Jumped Wednesday

    The news follows an announcement last week of Uxin's collaboration with the Alibaba subsidiary. A partnership between the two companies would not only bring Uxin's used car sales to the Taobao platform, but it would include posttransaction services, financing options, consumer protection policies, and a collaboration for an improved supply chain.

  • Hedge Funds Are Crazy About YY Inc (YY)
    Business
    Insider Monkey

    Hedge Funds Are Crazy About YY Inc (YY)

    Our calculations also showed that YY isn't among the 30 most popular stocks among hedge funds. In the financial world there are a large number of tools investors have at their disposal to grade stocks. A pair of the most under-the-radar tools are hedge fund and insider trading indicators.

  • Qualcomm presents evidence Apple breached court order
    Business
    CNBC Videos

    Qualcomm presents evidence Apple breached court order

    CNBC's David Faber reports on Qualcomm presenting evidence that Apple did breach a court order related to two Qualcomm patents.

  • 3 Top Medical Device Stocks to Buy Now
    Business
    Motley Fool

    3 Top Medical Device Stocks to Buy Now

    Healthcare providers tend to stay brand-loyal to medical devices after they've been trained on how to use them. This product stickiness is a key reason the industry is a great place to hunt for investment ideas. Align Technology (NASDAQ: ALGN), NovoCure (NASDAQ: NVCR), and DexCom (NASDAQ: DXCM) are three great examples of medical device makers that have already produced huge returns for shareholders. Align is the company behind the Invisalign system.

  • Finance
    Thomson Reuters StreetEvents

    Edited Transcript of TTNP earnings conference call or presentation 14-Nov-18 9:15pm GMT

    Q3 2018 Titan Pharmaceuticals Inc Earnings Call SOUTH SAN FRANCISCO Dec 11, 2018 (Thomson StreetEvents) -- Edited Transcript of Titan Pharmaceuticals Inc earnings conference call or presentation Wednesday, November 14, 2018 at 9:15:00pm GMT TEXT version

  • Business
    CNBC

    Deutsche Bank shares surge on report Germany plans to fix bank's problems with merger

    The German government is reportedly planning a push for a merger between Deutsche Bank and Commerzbank. Bloomberg News, citing sources, said Germany may change its tax law to aid the merger. Shares of Deutsche Bank DBK-DE surged Wednesday after Bloomberg News reported the German government plans to push for a merger to save the struggling bank.

  • EnLink Midstream Partners: Analysts’ Views and Target Price
    Business
    Market Realist

    EnLink Midstream Partners: Analysts’ Views and Target Price

    MLPs: Analyzing the Opportunities Ahead (Continued from Prior Part) EnLink Midstream Partners According to analysts’ estimates, EnLink Midstream Partners (ENLK) stock offers an upside potential of 39%—compared to its current market price of $12.82. Enlink Midstream Partners has a median target price of $17.83. Analysts seem to be cautious about the company.

  • Is Frontier Communications (FTR) a Great Value Stock Right Now?
    Business
    Zacks

    Is Frontier Communications (FTR) a Great Value Stock Right Now?

    Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. Looking at the history of these trends, perhaps none is more beloved than value investing. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.

  • Business
    Zacks

    Earnings Preview: General Mills (GIS) Q2 Earnings Expected to Decline

    Wall Street expects a year-over-year decline in earnings on higher revenues when General Mills (GIS) reports results for the quarter ended November 2018. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 19.

  • Business
    Motley Fool

    2 Big-Bank Stocks We're Watching Right Now

    Every week on Industry Focus: Financials, host Jason Moser and Motley Fool contributor Matt Frankel, CFP discuss one stock that's on top of their respective watch lists. Here's why Frankel thinks Bank of America (NYSE: BAC) is worth a look and why Moser says Wells Fargo (NYSE: WFC) could be a good value right now. Jason Moser: Alright, Matt, let's wrap this week up here with One to Watch.

  • Why Neurocrine Biosciences Is Tanking
    Business
    Motley Fool

    Why Neurocrine Biosciences Is Tanking

    This trial tested its drug Ingrezza (which is also called valbenazine) as a treatment for Tourette syndrome in children and adolescents. Unfortunately, the data from the trial showed that Ingrezza failed to meet the study's primary endpoint, as assessed by the Yale Global Tic Severity Scale (YGTSS). Here's the commentary that Neurocrine's CEO Kevin Gorman shared with investors: "We are very disappointed with the topline data from the T-Force GOLD study given that children and adolescents with Tourette syndrome need better treatment options.

  • Business
    Morningstar

    3 Ways to Reduce Risk in a Portfolio

    Idea 1: Make Your Equity Stake More Defensive Investors of all life stages could do well to make their equity stakes a little more defensive in this volatile market, but doing so is especially important for investors nearing retirement. "You might emphasize quality more," says Benz. "If you are an individual stock-picker, you might focus on what we call wide-moat companies.

  • Business
    CNBC

    If you invested $1,000 in Tesla in 2010, here's how much you'd have now

    Despite some lingering controversy around Tesla's co-founder and chief executive officer Elon Musk , the automaker's shares are up 37 percent in the past three months, and the company was a top performer in the Nasdaq 100 Monday, even amid steep stock market dips . If you invested in Tesla in 2010, when it made its initial public offering , that investment would have definitely paid off. A $1,000 investment would be worth more than $21,000 as of December 12, according to CNBC calculations, including price appreciation and dividend gains reinvested.

  • Finance
    Zacks

    LegacyTexas Financial (LTXB) Unveils Share Buyback Plan

    LegacyTexas Financial Group, Inc. LTXB continues to reward its shareholders through dividend hikes or additional share repurchases. The company recently announced a new share-buyback plan with authorization to repurchase around 5% of the total shares

  • Hedge Funds Are Betting On Shopify Inc (SHOP)
    Business
    Insider Monkey

    Hedge Funds Are Betting On Shopify Inc (SHOP)

    Shopify Inc (NYSE:SHOP) investors should pay attention to an increase in enthusiasm from smart money in recent months. SHOP was in 28 hedge funds' portfolios at the end of September. There were 25 hedge funds in our database with SHOP holdings at the end of the previous quarter.

  • Should You Buy United Natural Foods, Inc. (UNFI)?
    Business
    Insider Monkey

    Should You Buy United Natural Foods, Inc. (UNFI)?

    Let's look at how this market volatility affected the sentiment of hedge funds towards United Natural Foods, Inc. NASDAQ:UNFI), and what that likely means for the prospects of the company and its stock. United Natural Foods, Inc.